tiprankstipranks
Advertisement
Advertisement

AU:ACW Stock Latest News

Actinogen Medical Announces Employee Share Scheme Buy-Back
Company AnnouncementsActinogen Medical Announces Employee Share Scheme Buy-Back
9d ago
Actinogen opens long-term Xanamem extension in pivotal Alzheimer’s trial
PremiumCompany Announcements
Actinogen opens long-term Xanamem extension in pivotal Alzheimer’s trial
10d ago
Actinogen Director Geoffrey Brooke Increases Stake via Placement
PremiumCompany Announcements
Actinogen Director Geoffrey Brooke Increases Stake via Placement
16d ago
Actinogen issues director placement shares after shareholder approval
PremiumCompany Announcements
Actinogen issues director placement shares after shareholder approval
16d ago
Actinogen Medical Seeks ASX Quotation for 15.9 Million New Shares
PremiumCompany Announcements
Actinogen Medical Seeks ASX Quotation for 15.9 Million New Shares
16d ago
Actinogen secures $16.8m to fund pivotal Alzheimer’s trial beyond topline results
PremiumCompany AnnouncementsActinogen secures $16.8m to fund pivotal Alzheimer’s trial beyond topline results
24d ago
Actinogen Extends CEO Loan-Funded Incentive to Support Ongoing Equity Alignment
Premium
Company Announcements
Actinogen Extends CEO Loan-Funded Incentive to Support Ongoing Equity Alignment
27d ago
Actinogen Medical Seeks Quotation for Additional ASX Shares
Premium
Company Announcements
Actinogen Medical Seeks Quotation for Additional ASX Shares
1M ago
Actinogen Medical Seeks ASX Quotation for Over 113 Million New Shares
PremiumCompany Announcements
Actinogen Medical Seeks ASX Quotation for Over 113 Million New Shares
1M ago
Actinogen secures $16.8m to fund pivotal Alzheimer’s trial
PremiumCompany Announcements
Actinogen secures $16.8m to fund pivotal Alzheimer’s trial
1M ago
Actinogen Medical Adds 67,499 New Shares to ASX Quotation
PremiumCompany Announcements
Actinogen Medical Adds 67,499 New Shares to ASX Quotation
1M ago
Actinogen Medical Widens Half-Year Loss as R&D Spending Rises
PremiumCompany Announcements
Actinogen Medical Widens Half-Year Loss as R&D Spending Rises
1M ago
Actinogen boosts cash reserves with additional A$1.9m R&D tax rebate
PremiumCompany AnnouncementsActinogen boosts cash reserves with additional A$1.9m R&D tax rebate
2M ago
Actinogen Medical launches $5m digital-only share purchase plan for retail investors
Premium
Company Announcements
Actinogen Medical launches $5m digital-only share purchase plan for retail investors
2M ago
Actinogen launches discounted share purchase plan to fund Alzheimer’s trial
Premium
Company Announcements
Actinogen launches discounted share purchase plan to fund Alzheimer’s trial
2M ago
Actinogen Raises Capital via Institutional Share Placement to Support Late-Stage Trials
PremiumCompany Announcements
Actinogen Raises Capital via Institutional Share Placement to Support Late-Stage Trials
2M ago
Actinogen Seeks ASX Quotation for 269.8 Million New Shares
PremiumCompany Announcements
Actinogen Seeks ASX Quotation for 269.8 Million New Shares
2M ago
Actinogen Medical Seeks ASX Quotation for 190,228 New Shares
PremiumCompany Announcements
Actinogen Medical Seeks ASX Quotation for 190,228 New Shares
2M ago
Actinogen Medical Launches Securities Purchase Plan for Up to 119 Million New Shares
PremiumCompany Announcements
Actinogen Medical Launches Securities Purchase Plan for Up to 119 Million New Shares
2M ago
Actinogen Medical Plans Equity Issue of Up to 15.9 Million Shares
PremiumCompany AnnouncementsActinogen Medical Plans Equity Issue of Up to 15.9 Million Shares
2M ago
Actinogen Medical Plans Major Share Placement to Issue Up to 270 Million Shares
Premium
Company Announcements
Actinogen Medical Plans Major Share Placement to Issue Up to 270 Million Shares
2M ago
Actinogen Raises Up to A$17m to Fund Pivotal Alzheimer’s Trial Through to Final Results
Premium
Company Announcements
Actinogen Raises Up to A$17m to Fund Pivotal Alzheimer’s Trial Through to Final Results
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >